No. |
Cell type |
JCRB No.
|
Cell Name
|
Animal
|
Tissue
|
Profile
|
|
1 | general cells |
IFO50025 |
IM-9 |
human |
blood |
IgG-secreting B-lymphoblastic cell line. |
|
2 | general cells |
IFO50036 |
P388D1 |
mouse |
lymph node |
lymphoid neoplasm, derived from P388, (DBA/2 mouse) |
|
3 | general cells |
IFO50070 |
Balb/3T3-A31-1-1 |
mouse |
embryo, whole |
fibroblast, subclone of Balb/3T3-A31-1, (Strain problem was found. Refer Important Notice at cell detail page.) |
|
4 | general cells |
IFO50072 |
MRC-9 |
human |
lung |
Normal diploid fibroblasts with limited life span (crisis PDL = 44). |
|
5 | general cells |
IFO50077 |
IT-45R91 |
rat |
thymus |
thymic fibroblast, (Wistar rat) |
|
6 | general cells |
IFO50101 |
F2408-No.20 |
rat |
embryonic fibroblast |
Thymidine kinase-deficient line from F2408 (IFO 50015). |
|
7 | general cells |
IFO50110 |
C6 |
rat |
brain |
glial tumor, GFAP-positive |
|
8 | general cells |
IFO50268 |
EHS |
mouse |
spontaneous tumor |
This cell line secretes basement membrane matrix including laminin and type IV collagen. |
|
9 | general cells |
IFO50286 |
SF126 |
human |
brain |
glioblastoma multiforme, GFAP-negative |
|
10 | general cells |
IFO50313 |
SNG-M |
human |
metastatic lymph node |
endometrial adenocarcinoma |
|
11 | general cells |
JCRB0117 |
B104 |
human |
blood |
Human B cell lymphoma cell line with EBNA(-). IgD and IgM were expressed on the surface of cells. |
|
12 | general cells |
JCRB0132.3 |
AH601.P3(JTC27) |
rat |
acites |
AH-601 cell line adupted to a serum free medium with long passage history. |
|
13 | general cells |
JCRB0133 |
KHM-1B |
human |
pleural effusion |
myeloma, multiple, with hyperamylasemia. |
|
14 | general cells |
JCRB0136.2 |
CHO(pMAM-HSluc) |
hamster, Chinese |
genetically engineered CHO-K1 cells |
pMAM-HSluc transfected CHO-K1, HSP 70B gene promoter and luciferase reporter gene introduced |
|
15 | general cells |
JCRB0137 |
RERF-LC-KJ |
human |
lung |
adenocarcinoma, transplantable to SCID mice and frequently metastasize to lymph nodes |
|
16 | general cells |
JCRB0144.2D |
LYM-1.P3D |
rat |
lymph node near colon cancer |
Serum free FAR-2.F60 rat cell culture from lymph node near colon cancer. |
|
17 | general cells |
JCRB0149 |
Bhas 42 |
mouse |
whole body of embryo |
BALB 3T3 A31-1-1 cell line transfected with H-ras gene. The cell line keeps characteristics of the contact inhibition and the transfomation is induced by phorbol ester alone. No initialization required. (Strain problem was found. Refer Important Notice at cell detail page.) |
|
18 | general cells |
JCRB0161 |
Kasumi-4 |
human |
blood |
A novel human leukemia cell line established from a patient with chronic myelogenous leukaemia (CML) in blast crisis. |
|
19 | general cells |
JCRB0169 |
Lu-134-B |
human |
lung |
Small cell lung carcinoma cell line established through heterotransplanted tumor. |
|
20 | general cells |
JCRB0193 |
WB-F344 |
rat |
liver |
Normal liver epitherial cell line from rat, Fischer-344. |
|
21 | general cells |
JCRB0198 |
OSC-19 |
human |
tongue |
Human squamous cell carcinoma cell line from tongue tumor with serum free cell culture. |
|
22 | general cells |
JCRB0229 |
EGV-4T |
rat |
trachea |
immortal cell line from MNNG-transformed tracheal epithelial cells |
|
23 | general cells |
JCRB0246 |
RC-1 |
rabbit |
cornea |
cornea, (white rabbit) |
|
24 | general cells |
JCRB0248 |
ARLJ301-3 |
rat |
liver |
liver epithelial cell, (F344/DuCrj rat) |
|
25 | general cells |
JCRB0250 |
NEC8 |
human |
testis |
testicular germ cell tumor |
|
26 | general cells |
JCRB0262 |
T.T |
human |
esophagus |
Human squamous cell carcinoma derived from esophageal cancer. |
|
27 | general cells |
JCRB0263.1 |
PC12HS.P3 |
rat |
chromaffin cell |
Serum free NGF sensitive PC12HS cell line. |
|
28 | general cells |
JCRB0267 |
PC12MS |
rat |
chromaffin cell |
Moderately NGF sensitive clone of rat PC12 cell line. |
|
29 | general cells |
JCRB0416 |
Ac2F(DT) |
rat |
liver transformed |
Ac2F-derived, 3'-methyl-4-dimethylaminoazobenzene transformed, (Donryu rat) |
|
30 | general cells |
JCRB0426 |
HuH28 |
human |
liver bile duct |
Human liver, bile duct carcinoma cell line. |
|
31 | general cells |
JCRB0427 |
HuO9 |
human |
bone (right femur) |
A cell line established from a human osteosarcoma transplanted into athymic nude mice after fifth passages. The cell line expressed 1,25(OH)2D3-responsive alikaline phosphatase and produced tumors in the dorsum of nude mice. |
|
32 | general cells |
JCRB0435 |
JHH-4 |
human |
liver |
Human hepatocellular carcinoma cell line. |
|
33 | general cells |
JCRB0519 |
IMR-90-40 |
human |
lung |
Normal human fibroblast. |
|
34 | general cells |
JCRB0533 |
TIG-112 |
human |
skin |
skin, normal diploid fibroblast |
|
35 | general cells |
JCRB0536 |
TIG-121 |
human |
|
skin, normal diploid fibroblast |
|
36 | general cells |
JCRB0537 |
TIG-108 |
human |
skin |
skin, normal diploid fibroblast |
|
37 | general cells |
JCRB0538 |
TIG-109 |
human |
skin |
Normal diploid human skin cells. |
|
38 | general cells |
JCRB0704 |
FM3A TK~ |
mouse |
mammary gland |
mammary carcinoma, thymidine kinase-deficient FM3A, (C3H/He mouse) |
|
39 | general cells |
JCRB0710 |
EJ-1 |
human |
|
The cell line EJ-1 was identified to be the same cell line as the T24. |
|
40 | general cells |
JCRB0718.1 |
RLC-10.P3 |
rat |
liver |
Rat normal cell line cultured with serum free medium for long passages. |
|
41 | general cells |
JCRB0731 |
A9(3552)-2 |
human chromosome-introduced |
hybrid |
contains human chromosome 11pter>11q23::Xq26>Xqter (MTA with Tottori Univ. is required.) |
|
42 | general cells |
JCRB0814 |
VMRC-LCD |
human |
lung |
adenocarcinoma |
|
43 | general cells |
JCRB1001.1 |
MS-653-A |
rat |
tumor tissue |
Highly metastatic rat fibrosarcoma cell line induced by methylcholanthrene. |
|
44 | general cells |
JCRB1006.1F |
OUMS-36T-1F |
human |
embryo |
fibroblast, immortalized by hTRT, derivative of OUMS-36 |
|
45 | general cells |
JCRB1006.3 |
OUMS-36T-3 |
human |
embryo |
hTRT gene transfected normal human embryo fibroblast cell line. |
|
46 | general cells |
JCRB1006.4 |
OUMS-36T-4 |
human |
embryo |
hTRT gene transfected normal human embryo fibroblast cell line. |
|
47 | general cells |
JCRB1011 |
KMRC-2 |
human |
kidney |
Human tumor cell line from kidney. Clear cell renal carcinoma cell line. |
|
48 | general cells |
JCRB1015 |
HSC-1 |
human |
skin |
A cell line of a squamous cell carcinoma of human skin. |
|
49 | general cells |
JCRB1034 |
OUS-11 |
human |
lung normal tissue |
Normal human cell line from lung cancer patient. |
|
50 | general cells |
JCRB1052 |
PA-1/6TG-r |
human |
ascites fluid |
Human teratocarcinoma cell line PA-1 with 6TG resistance. |
|
51 | general cells |
JCRB1066 |
KMH-2 |
human |
cervical tumor |
Human anaplasitc thyroid carcinoma cell line with multidrug resistance, derived from a left cervical tumor with a sligt leukocytosis. |
|
52 | general cells |
JCRB1069 |
NOMO-1/ADM |
human |
peripheral blood |
leukemia, acute monocytic, adriamycin-resistant derivative of NOMO-1 |
|
53 | general cells |
JCRB1070 |
HSGc-C5 |
human |
floor of the mouth |
Human undifferentiated carcinoma cell line from floor of mouth (HeLa evidences observed). |
|
54 | general cells |
JCRB1074 |
FU97 |
human |
stomach |
Human stomach cancer cell line with AFP production. |
|
55 | general cells |
JCRB1075.0 |
IM95 |
human |
stomach |
Human gastric cancer cell line. |
|
56 | general cells |
JCRB1077 |
DD-762 |
mouse |
tumor tissue |
Mouse mammary tumor cell line producing MuMTV. |
|
57 | general cells |
JCRB1121 |
HEC-88nu |
human |
human tissue transplanted to mouse |
endometrial adenocarcinoma |
|
58 | general cells |
JCRB1137 |
UE6E7TC-4 |
human |
cartilage (DEC1 cells) |
Human immortalized mesenchymal cells derived from dedifferentiated chondrocyte, expressing mesenchymal stem cell markers. |
|
59 | general cells |
JCRB1138 |
NRG |
mouse |
Bone marrow |
Osteoblastic cell line of mouse C3H. |
|
60 | general cells |
JCRB1190 |
NCC-RbC-57 |
human |
primary retinoblastoma |
Human retinoblastoma cell line. |
|
61 | general cells |
JCRB1196 |
KMS-20 |
human |
bone marrow |
human myeloma cell line. |
|
62 | general cells |
JCRB1200 |
NCC-RbC-53 |
human |
primary retinoblastoma |
Human retinoblastoma cell line. The growth is extremely slow. |
|
63 | general cells |
JCRB1201 |
GCH-nu-YS |
human |
nude mouse-transplanted tumor |
Human gestational choriocarcinoma cell line. |
|
64 | general cells |
JCRB1202 |
KUM6 |
mouse |
Bone marrow |
Osteoblastic cell line |
|
65 | general cells |
JCRB1204 |
KUM7 |
mouse |
Bone marrow |
Osteoblastic cell line |
|
66 | general cells |
JCRB1222.05 |
HGH2.6.1 |
mouse |
|
Mouse hybridoma cell line producing monoclonal antibody against human growth hormone (hGH). |
|
67 | general cells |
JCRB1225 |
I51T |
mouse |
skin |
Mouse behta-galactosidase deficient cell line introduced human defcient bethta-galactosidase gene. |
|
68 | general cells |
JCRB1317 |
KCL-22 |
human |
pleural effusion |
Human myeloid cell line from chronic myelocytic leukemia. |
|
69 | general cells |
JCRB1333 |
NCC-CoC-K115L |
human |
Lymphatic node (colon) |
Human colon cancer cell line (metastasis peripheral lymph node). |
|
70 | general cells |
JCRB1335 |
HD-70 |
human |
peripheral blood |
Human Hodgkin's lymphoma cell line of B-cell origin. |
|
71 | general cells |
JCRB1342.05 |
MOR83.3.10 |
mouse |
|
Mouse hybridoma cell line producing monoclonal antibody against morphine. |
|
72 | general cells |
JCRB1342.07 |
MOR124.2.2 |
mouse x mouse |
|
Mouse hybridoma cell line producing monoclonal antibody against morphine. |
|
73 | general cells |
JCRB1343 |
OKa-C-1 |
human |
tumor in the left lung at autopsy, |
Lung cancer cell line producing both G-CSF and PTHrP. |
|
74 | general cells |
JCRB1344 |
delta-47 |
human |
ascites |
Human myeloma cell line secreting IgD. |
|
75 | general cells |
JCRB1365 |
Vn1919 cl4 |
mouse |
brain |
neuroglial and neuronal character coexpressing ependymoma cell line. |
|
76 | general cells |
JCRB1367 |
Vn1919 cl49 |
mouse |
brain |
neuroglial and neuronal character coexpressing ependymoma cell line. |
|
77 | general cells |
JCRB1368 |
Vn1919 cl59 |
mouse |
brain |
neuroglial and neuronal character coexpressing ependymoma cell line. |
|
78 | genetically-modified cells |
JCRB1371 |
GS-3A4-HepG2 |
human |
Liver |
Human glutamine synthetase gene and drug-metabolizing CYP3A4 gene introduced Hep G2 cells. |
|
79 | luciferase-expressing cancer cells |
JCRB1379 |
MKN45-Luc |
human |
stomach, metastatic tumor in liver |
Luciferase stably expressing cell line (MKN45:Human Gastric Cancer). |
|
80 | general cells |
JCRB1380 |
HBs320 |
mouse x mouse |
|
Mouse hybridoma cell line producing monoclonal antibody against HBs antigen. |
|
81 | general cells |
JCRB1381 |
HBs128 |
mouse x mouse |
|
Mouse hybridoma cell line producing monoclonal antibody against HBs antigen. |
|
82 | general cells |
JCRB1384 |
STR-428 |
human |
ascites |
Human HHV-8 negative malignant effusion lymphoma (DLBCL). |
|
83 | general cells |
JCRB1385 |
CAS-9 |
mouse x rat |
|
Hybridoma cell line producing antibody against mouse CD49d (VLA-4 a chain). Binding inhibition VLA-4/Fibronectin. |
|
84 | general cells |
JCRB1398 |
Kasumi-5 |
human |
blood |
T cell leukemia |
|
85 | general cells |
JCRB1401 |
Kasumi-7 |
human |
blood |
B cell leukemia |
|
86 | luciferase-expressing cancer cells |
JCRB1406 |
PC-3-Luc |
human |
prostate |
Luciferase stably expressing cell line (PC-3; Human Prostate Cancer). |
|
87 | general cells |
JCRB1410 |
Kasumi-10 |
human |
blood |
B cell leukemia |
|
88 | luciferase-expressing cancer cells |
JCRB1448 |
BxPC-3-Luc#2 |
human |
pancreas |
Luciferase stably expressing cell line (BxPC-3; Human pancreatic adenocarcinoma cell line). |
|
89 | luciferase-expressing cancer cells |
JCRB1474 |
B16-F0-Luc |
mouse |
skin |
Luciferase stably expressing cell line (B16-F0; Mouse melanoma cell line). |
|
90 | luciferase-expressing cancer cells |
JCRB1486 |
NCI-H1975-Luc |
human |
|
Luciferase stably expressing cell line (NCI-H1975; Human lungadenocarcinoma cell line). |
|
91 | genetically-modified cells |
JCRB1494 |
POLZ KO MSH- |
human |
peripheral blood |
Human cell line derived from B cell leukemia. (MSH-, POLZ KO/KO, TK+/+) |
|
92 | luciferase-expressing cancer cells |
JCRB1497 |
NCI-H441/CMV-Luc |
human |
|
Luciferase stably expressing cell line (NCI-H441; Human lung papillary adenocarcinoma cell line). |
|
93 | luciferase-expressing cancer cells |
JCRB1508 |
HCC-1937/CMV-Luc |
human |
mammary gland; breast |
Luciferase stably expressing cell line (HCC1937; Human breast cancer cell line). |
|
94 | genetically-modified cells |
JCRB1510 |
POLZ Y2779F |
human |
peripheral blood |
Human cell line derived from B cell leukemia. (MSH+, POLZ low activity, TK+/-) |
|
95 | genetically-modified cells |
JCRB1523 |
POLK CD MSH- |
human |
peripheral blood |
Human cell line derived from B cell leukemia. (MSH-, POLK catalytically dead, TK+/+) |
|
96 | genetically-modified cells |
JCRB1533 |
293 TRE/Cont |
human |
kidney |
Control 293 cell line for 293 TRE/FLAG-POLK. |
|
97 | genetically-modified cells |
JCRB1534 |
IKK-i-DEF |
mouse |
embryo |
Mouse embryonic fibroblasts prepared from IkB kinase (IKK-i) deficient mice. |
|
98 | genetically-modified cells |
JCRB1538 |
EMC100 |
human |
uterine endometrium |
Immortalized human uterine endometrial gland-derived mesenchymal cell line. |
|
99 | general cells |
JCRB1539 |
HAC-2 |
human |
ascites |
Human ovary cancer cell line derived from mesonephros. |
|
100 | genetically-modified cells |
JCRB1544 |
EMC214 |
human |
uterine endometrium |
Immortalized human uterine endometrial gland-derived mesenchymal cell line. |
|
101 | genetically-modified cells |
JCRB1545 |
EM-E6/E7/hTERT-2 |
human |
uterine endometrium |
Immortalized human uterine endometril progenitor cell line. |
|
102 | immortalized mesenchymal stem cell |
JCRB1546 |
UCB408E7-TERT34 |
human |
umbilical cord blood |
Immortalized human umbilical cord blood-derived mesenchymal stem cells. |
|
103 | luciferase-expressing cancer cells |
JCRB1549 |
SK-OV-3-Luc |
human |
|
Luciferase stably expressing cell line (SK-OV-3; Human ovarian cancer cell line). |
|
104 | genetically-modified cells |
JCRB1550 |
HAdpc-25-Bmi-1-TERT |
human |
|
Immortalized human adipose tissue-derived mesenchymal stem cells. |
|
105 | genetically-modified cells |
JCRB1554 |
MMNK-1 |
human |
|
Highly differentiated immortalized human cholangiocyte cell line. |
|
106 | genetically-modified cells |
JCRB1555 |
HAdpc-26-E6-Bmi-1-TERT |
human |
|
Immortalized human adipose tissue-derived mesenchymal stem cells. |
|
107 | genetically-modified cells |
JCRB1563 |
HAdpc-29-E7-TERT |
human |
|
Immortalized human adipose tissue-derived mesenchymal stem cells. |
|
108 | genetically-modified cells |
JCRB1564 |
TMNK-1 |
human |
liver |
Immortalized human-liver endothelial cell line with SV40T and hTERT. (Note: recommended medium is very specific.) |
|
109 | general cells |
JCRB1566 |
NP 2 |
human |
brain |
Human cell line derived from human glioma. |
|
110 | general cells |
JCRB1568 |
KKU-100 |
human |
biliary tract |
Human poorly differentiated cholangiocarcinoma cell line established from biliary tract. |
|
111 | general cells |
JCRB1571 |
F6B3 |
mouse |
brain |
Mouse cell line derived from mouse brain tumor. |
|
112 | luciferase-expressing cancer cells |
JCRB1586 |
HSC-5-Luc |
human |
skin |
Luciferase stably expressing cell line. A cell line derived from human skin squamous cell carcinoma having anaplastic epithelioid features. |
|
113 | luciferase-expressing cancer cells |
JCRB1592 |
Hep G2-Luc |
human |
differentiated liver carcinoma |
Luciferase stably expressing cell line (Hep G2: Human Hepatoma Cell Line). |
|
114 | general cells |
JCRB1603 |
hTf18-10C |
mouse x mouse |
|
This cell line produce monoclonal antibody against human transferrin. |
|
115 | general cells |
JCRB1616 |
hTf/CHO-S #17 |
hamster, Chinese |
ovary |
This cell line produce human transferrin. |
|
116 | general cells |
JCRB1617 |
hTf9-11E |
mouse x mouse |
|
This cell line produce monoclonal antibody against human transferrin. |
|
117 | general cells |
JCRB1626 |
pREP4 cont/CHO-S #5 |
hamster, Chinese |
ovary |
pREP4-cont transfected CHO-S cells (cell freezed by 10% DMSO + 90% FBS). |
|
118 | genetically-modified cells |
JCRB1630 |
DR-EcoScreen |
mouse |
Liver (Hepa1c1c7 cell derivative) |
DR-EcoScreen is for evaluation of a rapid in vitro aryl hydrocarbon receptor tarnscriptional activation assay. |
|
119 | general cells |
JCRB1647 |
28SC-ES |
human |
peripheral bood |
endotoxin sensitive human peripheral blood cell line (Believed to be derived from U937 cells). |
|
120 | luciferase-expressing cancer cells |
JCRB1681 |
MIA PaCa-2/CMV-Luc |
human |
pancreas |
Luciferase stably expressing cell line (MIA PaCa-2; Human Pancreatic Cancer Cell Line). |
|
121 | genetically-modified cells |
JCRB1697 |
HepaMN |
human |
liver |
Immortalized human liver cell line |
|
122 | luciferase-expressing cancer cells |
JCRB1716 |
Ex-3LL/CMV-Luc#1 |
mouse |
|
Luciferase stably expressing cell line (Ex-3LL; Variant cell line possessing enhanced lung metastasis ability derived from Lewis lung cancer). |
|
123 | genetically-modified cells |
JCRB1736 |
293_hSyn1 |
human |
kidney |
293 cell line into which human Syndecan-1 gene has been transfected. |
|
124 | general cells |
JCRB1771 |
KKK-D049 |
human |
intrahepatic bile duct |
Human well differentiated tubular adenocarcinoma cell line established from biliary tract. |
|
125 | general cells |
JCRB1777 |
KKK-D131 |
human |
intrahepatic bile duct |
Human well differentiated tubular adenocarcinoma cell line established from biliary tract. |
|
126 | general cells |
JCRB1788 |
BALM-9KL |
human |
peripheral blood |
B cell leukemia cell line |
|
127 | general cells |
JCRB1806 |
PIS-1 |
human |
lung |
Human pulmonary intimal sarcoma |
|
128 | general cells |
JCRB1808 |
MOLM-1 |
human |
|
Human megakaryobalastoid cell line |
|
129 | general cells |
JCRB1823 |
NALM-20 |
human |
peripheral bood |
Biphenotypic (B-cell and myeloid cell features) t(9;22)-positive leukemic cell line. |
|
130 | general cells |
JCRB1825 |
NALM-21 |
human |
perpheral blood |
Biphenotypic (B-cell and myeloid cell features) t(9;22)-positive leukemic cell line. Recurrence of the same patient as NALM-20.
|
|
131 | general cells |
JCRB1830 |
NALM-27 |
human |
peripheral bood |
Biphenotypic (B-cell and myeloid cell features) acute leukemia cell line with a Variant Ph Translocation t(9;22;10)(q34;q11;q22). |
|
132 | genetically-modified cells |
JCRB1845 |
HeLa-ACE2 |
human |
cervix |
HeLa cells expressing angiotensin-converting enzyme-related carboxypeptidase (ACE2). Recommended use:Comparative control with HeLa-ACE2-TMPRSS2 cells |
|
133 | general cells |
JCRB1855 |
Cx43KOM104-E7(+/+) |
mouse |
embryo, whole |
Connexin 43 +/+ mouse embryo-derived fibroblast cell line. (embryo from Connexin 43 +/- parents) |
|
134 | general cells |
JCRB1856 |
NALM-37 |
human |
peripheral bood |
B-cell precurrsor (BCP) acute lymphoblastic leukemia (ALL) cell line. Derived from the same patient as NALM-36 |
|
135 | general cells |
JCRB1864 |
HSC-39 |
human |
ascites |
Human signet ring cell gastric carcinoma cell line establised in vitro from ascites. |
|
136 | general cells |
JCRB1885 |
HSC-64 |
human |
ascites |
Human gastric carcinoma (poor differentiated adenocarcinoma) cell line establised in vitro from ascites. |
|
137 | general cells |
JCRB1892 |
OCUT-3 |
human |
lymph node |
human anaplastic thyroid cancer cell line |
|
138 | general cells |
JCRB1916 |
TCC-NECT-2 |
human |
duodenum |
Duodenal neuroendocrine tumor. Derived from metastatic site: Ascites. |
|
139 | general cells |
JCRB1917 |
Sui70 |
human |
pancreas |
Pancreatic adenocarcinoma. Cell line established by forming xenograft tumor (PDX) from pancreas adenocarcinoma. |
|
140 | general cells |
JCRB1986 |
UCCA-24 |
human |
primary rectum carcinoma |
Derived from colorectal cancer with ulcerative colitis. Isolated as poorly differentiated adenocarcinoma by cloning. |
|
141 | general cells |
JCRB4004 |
KE-43C4 |
human |
primary colonic carcinoma |
Well-differentiated adenocarcinoma obtained by cloning KE-43 |
|
142 | genetically-modified cells |
JCRB4005 |
MDCK-4KO-EKARrEV-NLS-EGF |
dog |
kidney |
MDCK-4KO-EKARrEV-NLS expressing UbC-canisEGF. |
|
143 | general cells |
JCRB4060 |
EHMK-51-35 |
human |
lung |
A cell line (EHMK-51-35) cloned from EHMK cells derived from human lung adenocarcinoma as carrier cells for a midkine promoter-driven oncolytic adenovirus. EHMK is a subline of A549. |
|
144 | general cells |
JCRB9036 |
104C1 |
guinea pig |
fetal body |
fetal carcass, benzo(a)pyrene transformed, diploid |
|
145 | general cells |
JCRB9039 |
Pt K1 |
marsupial (potoroo, rat kangar |
kidney |
kidney |
|
146 | general cells |
JCRB9087 |
RPMI 1846 |
hamster, Syrian |
melanotic melanoma |
melanotic melanoma |
|
147 | general cells |
JCRB9108 |
J774A.1 |
mouse |
ascites |
Mouse macrophage cell line. |
|
148 | general cells |
JCRB9118 |
SCC-4 |
human |
tongue |
squamous carcinoma, tongue |
|
If you wish you add additional cell lines to your order, please click the "Additional order" button below.
It will close the current window and allow you to add additional cell lines to your order.
If you are ready to proceed and place your order, please click on the "Order form (SSL)" button below.